The Full Spectrum of News.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Memorial Day
Social Media
Artificial Intelligence
Donald Trump
US Politics
Republican Party
Education
Senate
Natural Disasters
FBI
Democratic Party
Nvidia
Published • loading... • Updated

US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon HADLIMA™ (adalimumab-bwwd) Injection

Summary by Enid News & Eagle
INCHEON, Korea & JERSEY CITY, N.J.--(BUSINESS WIRE)--May 27, 2025-

2 Articles

All
Left
1
Center
1
Right
Mid Florida NewspapersMid Florida Newspapers
Reposted by
Enid News & EagleEnid News & Eagle
Center

US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon HADLIMA™ (adalimumab-bwwd) Injection

INCHEON, Korea & JERSEY CITY, N.J.--(BUSINESS WIRE)--May 27, 2025-

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Enid News & Eagle broke the news in on Tuesday, May 27, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

FDA

FDA

Jersey City

Jersey City

News
For You
SearchBlindspotLocal